Methods to improve glucose tolerance in a subject by administering an antibody that binds to extracellular human metallothionein 1A (MT1A)
US-12583916-B2 · Mar 24, 2026 · US
Joslin Diabetes Center Inc holds 18 patents in our database, with recent filings and technology areas summarized below.
| Metric | Value |
|---|---|
| Total patents | 18 |
| Recent patents | 7 |
| First publication | Feb 26, 2015 |
| Latest publication | Mar 24, 2026 |
Year-over-year patent counts for this assignee.
Latest publications where this party is an assignee.
US-12583916-B2 · Mar 24, 2026 · US
US-2025361505-A1 · Nov 27, 2025 · US
US-12161463-B2 · Dec 10, 2024 · US
US-2024091441-A1 · Mar 21, 2024 · US
US-2024067710-A1 · Feb 29, 2024 · US
Representative or frequently cited publications from precomputed assignee stats.
US-12583916-B2 · Mar 24, 2026 · US
US-2025361505-A1 · Nov 27, 2025 · US
US-12161463-B2 · Dec 10, 2024 · US
US-2024091441-A1 · Mar 21, 2024 · US
US-2024067710-A1 · Feb 29, 2024 · US
Most common classification codes in this portfolio.
| CPC | Patents |
|---|---|
| A61P3/10 | 7 |
| A61K38/1709 | 7 |
| A61P1/16 | 6 |
| A61P29/00 | 5 |
| A61K48/005 | 5 |
Mapped technology topics for this assignee.
| Technology | Patents |
|---|---|
| Human Necessities | 17 |
| Chemistry & Metallurgy | 13 |
| Physics | 5 |
| Cross-Sectional Technologies | 2 |
Answers are generated from the same data shown on this page.